Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 31,350 | 0.0% | 527,507 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 33,052 | 0.0% | 610,275 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 40,302 | 0.0% | 733,166 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 59,082 | 0.0% | 835,795 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 55,862 | 0.0% | 849,865 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 59,943 | 0.0% | 852,797 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 73,283 | 0.1% | 890,108 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 96,512 | 0.1% | 1,105,016 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 110,852 | 0.1% | 1,149,676 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 102,881 | 0.1% | 1,162,763 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 101,184 | 0.1% | 1,167,331 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 115,456 | 0.1% | 1,187,327 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 127,633 | 0.1% | 1,233,289 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 112,321 | 0.1% | 1,325,008 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 110,376 | 0.1% | 1,331,921 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 105,157 | 0.1% | 1,363,906 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 123,166 | 0.1% | 1,394,072 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 108,500 | 0.1% | 1,403,799 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 108,175 | 0.1% | 1,296,440 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 69,674 | 0.1% | 922,713 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 82,049 | 0.1% | 935,672 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 69,232 | 0.1% | 909,984 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 100,104 | 0.1% | 811,610 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 33,891 | 0.0% | 401,080 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 35,938 | 0.0% | 425,046 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 20,410 | 0.0% | 323,465 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 21,700 | 0.0% | 311,200 | 12/31/2013 |